Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revelation Biosciences Inc (REVB)

Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Revelation Biosciences Inc 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 USA

www.revbiosciences.com Employees: 9 P: 650-800-3717

Sector:

Medical

Description:

Revelation Biosciences Inc. is a clinical-stage life sciences company. It focused on the development of immunologic-based therapies for the prevention and treatment of disease. The company's product pipeline includes REVTx-99, REVTx-200 and REVDx-501. Revelation Biosciences Inc., formerly known as Petra Acquisition Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 9,309
Enterprise Value, $K 2,809
Shares Outstanding, K 6,896
Float, K 6,341
% Float 91.96%
Short Interest, K 258
Short Float 3.74%
Days to Cover 1.00
Short Volume Ratio 0.48
% of Insider Shareholders 8.04%
% of Institutional Shareholders 12.80%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -15,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,910 K
EBIT, $ -8,240 K
EBITDA, $ -8,210 K

Growth:

1-Year Return -97.31%
3-Year Return -99.99%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.77 on 11/06/25
Next Earnings Date 03/05/26 [--]
Earnings Per Share ttm -120.21
EPS Growth vs. Prev Qtr 74.75%
EPS Growth vs. Prev Year 95.61%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 01/28/26

REVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -145.03%
Return-on-Assets % -112.72%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.12
Book Value/Share 12.22
Interest Coverage -2.40
60-Month Beta -0.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar